Indopoly Swakarsa Industry Tbk vs Merck Tbk. — how do they compare? Indopoly Swakarsa Industry Tbk trades at Rp106 (market cap 689.44B, 236.1K 24h volume), while Merck Tbk. trades at Rp3,840 (market cap 1.7T, 37.6K 24h volume). The key difference: Merck Tbk. is far larger — about 2.5× Indopoly Swakarsa Industry Tbk's market cap, and Indopoly Swakarsa Industry Tbk is more actively traded (236.1K versus 37.6K). Which is the better fit depends on your goals.
| IPOL | MERK | |
|---|---|---|
Market Cap | 689.44B | 1.7T |
Volume | 236.1K | 37.6K |
Lot | 2.36K | 376 |
Turnover | 25.04M | 144.47M |
Average Price | 106.05 | 3,842.23 |
Value | 25.04M | 144.47M |
Indicative Equilibrium Price | 106 | 3,840 |
Indicative Equilibrium Volume | 18 | 7 |
Trailing returns across standard periods
Latest headlines on both assets
PT Indopoly Swakarsa Industry (the company) was established on 24 Mar 1995 based on Notaries Deed No. 114 and the deed of establishment was approved by the the Ministry of Justice dated Dec 22, 1995. The Company’s articles of association has been amended several times, most recently by notarial deed No. 5 of Popie Savitri, S.H., dated Mar 1, 2010, concerning among others, the change in the Company’s name, and public offering.
Read more on IPOL →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Read more on MERK →